Treatment of Sinistral Portal Hypertension via Robotic Assisted Laparoscopic Splenectomy: The First Reported Case
Document Type
Conference Proceeding - Restricted Access
Publication Date
5-9-2025
Abstract
Sinistral portal hypertension (SPH), also known as left-sided portal hypertension, is a clinical entity that can result in upper gastrointestinal (UGI) bleeding in the absence of liver damage or dysfunction. Resulting from blockage of the splenic vein, SPH is a rare occurrence, with less than 500 cases being reported worldwide. Of these cases, it is estimated that only 4-17% of patients with SPH will experience UGI bleeding. While there are no set guidelines for the treatment of SPH, data support surgical intervention for symptomatic patients and surveillance for asymptomatic patients. For patients with hematemesis due to varices, the treatment most advocated for is splenectomy via laparoscopic approach. More recently, preoperative embolization of the splenic artery has been shown to reduce intraoperative blood loss and decrease operation time without increasing complications.
Recommended Citation
DeJonge J, Lucas A, Kronner D, Alashari A. Treatment of sinistral portal hypertension via robotic assisted laparoscopic splenectomy: the first reported case. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.
Comments
2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1811